About Welldoc
Welldoc is a company based in Columbia (United States) founded in 2005. Welldoc has raised $72.08 million across 10 funding rounds from investors including ARE, Samsung Venture Investment and Merck Global Health Innovation Fund. The company has 163 employees as of April 07, 2024. Welldoc has completed 1 acquisition, including Home Health Specialists. Welldoc offers products and services including BlueStar and Welldoc App. Welldoc operates in a competitive market with competitors including DarioHealth, Wellthy Therapeutics, Pear Therapeutics, Spiras Health and Ciba Health, among others.
- Headquarter Columbia, United States
- Employees 163 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Welldoc Software Private Limited
- Date of Incorporation 21 Jul, 2009
- Jurisdiction Bangalore South, Karnataka, India
-
Annual Revenue
$3.71 M (USD)43.11as on Mar 31, 2023
-
Net Profit
$199.95 K (USD)117.5as on Mar 31, 2023
-
EBITDA
$461.19 K (USD)83.59as on Mar 31, 2023
-
Total Equity Funding
$72.08 M (USD)
in 10 rounds
-
Latest Funding Round
$7.5 M (USD), Series B
Mar 01, 2016
-
Investors
ARE
& 8 more
-
Employee Count
163
as on Apr 07, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Welldoc
Welldoc offers a comprehensive portfolio of products and services, including BlueStar and Welldoc App.
FDA-cleared app for tracking and managing type 1 and type 2 diabetes.
Platform for self-management of various chronic conditions like hypertension.
People of Welldoc
Unlock access to complete
Unlock access to complete
Leadership Team
11 people
Sales and Marketing
10 people
Product Management Team
6 people
Software Development Team
4 people
Human Resources and Administration
4 people
Board Team
2 people
Creative and Marketing Team
2 people
Data Analysis and Operations Team
2 people
Unlock access to complete
Funding Insights of Welldoc
Welldoc has successfully raised a total of $72.08M across 10 strategic funding rounds. The most recent funding activity was a Series B round of $7.5 million completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Welldoc
Welldoc has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Samsung Venture Investment and Merck Global Health Innovation Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital is focused on the life science sector.
|
Locked | Locked | Locked | |
|
Early to late stage VC firm investing in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Welldoc
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Welldoc
Welldoc has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Home Health Specialists.
Investment portfolio details for Welldoc
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Home nursing care services are provided to patients in residences.
|
Locked | Locked | 1984 | Locked |
Complete acquisition details for Welldoc
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Welldoc
Detailed financials for Welldoc
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Welldoc Comparisons
Peer comparison for Welldoc
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Welldoc
Welldoc operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DarioHealth, Wellthy Therapeutics, Pear Therapeutics, Spiras Health and Ciba Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Chronic conditions are managed via a personalized digital platform.
|
|
| Locked | Locked | Locked |
Health monitoring app is provided for chronic patients and providers.
|
|
| Locked | Locked | Locked |
Pear Therapeutics provides cloud-based digital solutions for managing chronic health conditions effectively.
|
|
| Locked | Locked | Locked |
Asthma and COPD symptoms are managed through clinical services.
|
|
| Locked | Locked | Locked |
Provider of teleconsultation and digital therapeutic software for employees and patients
|
Detailed competitors of Welldoc
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Welldoc
Complete news archive for Welldoc
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Welldoc
Welldoc was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Welldoc is headquartered in Columbia, United States.
Kevin P McRaith is the current CEO of Welldoc.
Welldoc is a funded company, having raised a total of $72.08M across 10 funding rounds to date.
As of Apr 07, 2024, the latest employee count at Welldoc is 163.
Annual revenue of Welldoc is $3.71M as on Mar 31, 2023.
Welldoc was founded in 2005 and is headquartered in Columbia, United States. Operations focus on the mobile health sector, where chronic disease management is supported through prescription-based digital tools. The flagship product, BlueStar, delivers real-time coaching for diabetes self-management using algorithms that analyze patient data. This therapy is prescribed by healthcare providers and can be obtained via pharmacies for reimbursement purposes.
Welldoc's top competitors include Wellthy Therapeutics, DarioHealth and Ciba Health.
Welldoc offers BlueStar and Welldoc App.
Welldoc has made 1 acquisition, including Home Health Specialists.
Welldoc has 9 investors. Key investors include ARE, Samsung Venture Investment, Merck Global Health Innovation Fund, Adage Capital Management, and Excel Venture Management.